Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | C134-HSV-1 |
Synonyms | |
Therapy Description |
C134-HSV-1 is an oncolytic HSV/HCMV chimeric virus that potentially induces tumor cell death and anti-tumor immune response (PMID: 29216507). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
C134-HSV-1 | C134|C-134|C 134|HSV-1 C134 | C134-HSV-1 is an oncolytic HSV/HCMV chimeric virus that potentially induces tumor cell death and anti-tumor immune response (PMID: 29216507). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06614855 | Phase I | C134-HSV-1 | A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma | Not yet recruiting | USA | 0 |
NCT03657576 | Phase I | C134-HSV-1 | Trial of C134 in Patients With Recurrent GBM (C134-HSV-1) | Active, not recruiting | USA | 0 |
NCT06193174 | Phase I | C134-HSV-1 | Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) | Not yet recruiting | USA | 0 |